Experimental study finds Kelulut honey enhances bone microarchitecture and antioxidant enzymes in diet-compromised rats, indicating potential to mitigate metabolic skeletal deterioration.
Background: High-carbohydrate high-fat (HCHF) diets have been associated with oxidative stress, impaired bone remodelling, and deterioration of skeletal integrity. Kelulut honey (KH), a stingless bee honey rich in antioxidant compounds, has demonstrated protective effects against bone loss; however, its effects on bone density, biomechanical properties, antioxidant status, and bone-related molecular markers remain incompletely understood. (2) Methods: Male Wistar rats were assigned to sham, negative control (NC), or KH-treated groups (200, 400, and 600 mg/kg). The NC and KH groups received an HCHF diet for 24 weeks, with KH administered during the final 12 weeks. Bone microarchitecture was evaluated using micro-computed tomography, bone mineral density (BMD) by dual-energy X-ray absorptiometry, and biomechanical properties by three-point bending. Antioxidant enzyme activities, serum bone turnover markers, and bone-related gene expression were also assessed. (3) Results: HCHF feeding reduced BMD, load, stress, Young’s modulus, gluthatione peroxidase (GPx) activity, and superoxide dismutase (SOD) activity while increasing strain, displacement, serum C-terminal telopeptide of type 1 collagen (CTX-1) and receptor activator of nuclear factor-κB (RANK) levels, and runt-related transcription factor 2 (Runx2) expression. KH supplementation improved bone health by dose-dependently enhancing antioxidant defences, significantly increasing GPx and SOD activities, while catalase (CAT) activity was elevated at 600 mg/kg. The 400 mg/kg dose improved trabecular microarchitecture by increasing trabecular number, connectivity density and cortical area/total tissue area. KH also improved biomechanical properties, increasing load, stress, stiffness, and Young’s modulus while reducing displacement. Furthermore, KH attenuated HCHF-induced increases in Runx2 mRNA and RUNX2 protein and reduced osterix (Sp7), integrin Subunit Alpha 5 (Itga5), and calcitonin receptor (Calcr) mRNA expression. However, serum CTX-1 remained elevated in all KH-treated groups. (4) Conclusions: Overall, the findings suggest that KH may have potential as a natural intervention for mitigating diet-associated skeletal alterations, although further studies are required to clarify the underlying mechanisms.
No takes yet. Share an insight, caveat, or question.
Ekeuku et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: